Brexit

MHRA Post-Transition Period Information

MHRA Post-Transition Period Information

Clinical Trial Authorisations (CTA) - December 2020 Our Regulatory Affairs Team focus on the important information you need, as we approach the end of the BREXIT transition period. How will Brexit impact my clinical trial? MHRA has published several updates…
MHRA Submissions – The UK submissions portal from 01 January 2021

MHRA Submissions – The UK submissions portal from 01 January 2021

Following the end of the Brexit transition period in January, submissions relating to Clinical Trial Authorisations and Marketing Authorisations in the UK will need to be submitted via MHRA Submissions Portal, not CESP. MHRA Submissions First Step The first step…
Clinical Trials News from around the Globe

Clinical Trials News from around the Globe

With COVID-19 dominating clinical trials news, our latest industry update includes coverage of the key guidance documents issued by the regulators and much more. Compiled by Christina Hägglund, QA Manager, S-cubed Ltd. You can download the pdf of this update…
Clinical Development Practices & Regulations

Clinical Development Practices & Regulations

Clinical Development Practices and Regulations are the main focus for our Q2 Industry Update. We also include important information about COVID-19, expertly compiled by Christina Hägglund, QA Manager, S-cubed Ltd. Read all the latest regulatory news here. You can download…
Clinical Trial Regulation, ICH E6(R2) & Brexit

Clinical Trial Regulation, ICH E6(R2) & Brexit

Clinical Trial Regulation, ICH E6(R2), Brexit and much more feature in our Q1 Industry Update, compiled by Christina Hägglund, QA Manager S-cubed Ltd. Read all the latest regulatory news here. You can download the pdf of this update here and…